デフォルト表紙
市場調査レポート
商品コード
1466369

臨床試験施設管理機関市場:フェーズ、サービス、治療分野別-世界予測2024-2030年

Clinical Trials Site Management Organizations Market by Phase (Phase I, Phase II, Phase III), Services (Onsite Monitoring, Project Management, Regulatory Compliance), Therapeutic Areas - Global Forecast 2024-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 197 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.74円
臨床試験施設管理機関市場:フェーズ、サービス、治療分野別-世界予測2024-2030年
出版日: 2024年04月17日
発行: 360iResearch
ページ情報: 英文 197 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臨床試験施設管理機関市場規模は2023年に73億8,000万米ドルと推定され、2024年には80億米ドルに達し、CAGR 8.65%で2030年には132億1,000万米ドルに達すると予測されます。

臨床試験施設管理組織は、臨床試験のさまざまな段階において、患者の募集、スタッフの研修や会議の調整、試験予算の管理などを担当します。また、治験施設が関連規制を遵守していることを確認し、治験参加者全員が質の高いケアを受けられるようにする支援も行っています。感染症や非感染症の流行が医薬品開発活動を後押しする中、治験施設管理機関の利用は近年大幅に増加しています。さらに、政府機関や製薬・バイオ医薬品メーカーによる投資、臨床試験活動の費用対効果に優れた管理の必要性も、施設管理機関の利用を後押ししています。その一方で、様々な臨床試験実施施設の管理・調整に関する問題や訓練されたスタッフの不足が、治験施設管理機関の利用を妨げています。しかし、臨床試験管理およびモニタリングにおける革新的な技術の採用は、世界中の研究施設数の継続的な増加と相まって、今後数年間の臨床試験施設管理サービスの採用を支援すると予想されます。

主な市場の統計
基準年[2023] 73億8,000万米ドル
予測年[2024] 80億米ドル
予測年 [2030] 132億1,000万米ドル
CAGR(%) 8.65%

フェーズ第III相臨床試験における厳密なデータ収集と参加者管理の必要性

第I相臨床試験プロセスにおいて、治験施設管理機関は、詳細なプロトコールの作成、全体的な試験計画の厳守、目標に対する進捗状況の綿密なモニタリング、関係者間の明確なコミュニケーションの提供、規制当局との調整を支援します。さらに、これらの組織は、正確なデータ収集のために適切な患者集団が登録されるよう、募集活動を監視することもあります。第Ⅱ相臨床試験において、治験施設管理機関は、サンプル数の増加に伴う業務量の増加に対応するために必要なスタッフの増員、参加者の訪問及びフォローアップ検査の増加に対応するための十分なリソースの提供、参加者からの質の高いデータの正確かつ効率的な収集、全ての任務が組織的かつ適時に完了するための支援に重点を置く。第III相臨床試験中、治験施設管理機関は、常に患者の安全を守りながら、データの正確性と一貫性に関する厳格な基準を維持するよう努める。全プロセスを通じた厳格な品質管理対策などの戦略は、データの完全性と規制基準の遵守を保証するのに役立ちます。第IV相臨床試験において、治験施設管理機関の主な目標は、追加的な患者追跡調査や追加的な臨床検査などの継続的な市販後調査活動を通じて、試験対象の医薬品または医療機器の長期的な安全性と有効性を評価・判定することです。

治療領域:腫瘍学試験特有の複雑性、迅速な開発サイクルと広範な多施設調整の必要性

心臓病学は、心臓と血管に関連する疾患の診断、理解、治療に重点を置く分野です。循環器科の臨床試験は、高血圧、冠動脈疾患、心不全、不整脈を管理するための予防法や新規治療法を調査するものから、ステントやペースメーカーなどの最先端医療機器を評価するものまで、広範な研究を包含する可能性があります。中枢神経系領域は、アルツハイマー病、パーキンソン病、てんかん、うつ病、統合失調症など、さまざまな神経学的・精神医学的疾患を包含しており、試験の複雑さが際立っています。これは、しばしば主観的であったり、特別な器具を必要としたりするアウトカムの測定が複雑であるためです。治験施設管理機関はCNS試験において重要な役割を担っており、厳しい規制環境を乗り切り、患者評価とアウトカム測定のための特殊な手法の導入を促進しています。内分泌系試験は、糖尿病、甲状腺疾患、骨粗鬆症などの内分泌系の疾患に焦点を当てたものです。内分泌系試験、特に糖尿病に関連する試験の多くは、大規模な患者登録と長期フォローアップを必要とする大規模試験であるが、運営上の要求は内分泌系疾患のスペクトラムによって大きく異なります。臨床試験施設管理機関は、これらの試験において、特に特定の亜集団へのアプローチや長期フォローアップのロジスティック管理など、患者のリクルートに関する専門知識を提供し、役立っています。がん領域は、治験施設管理機関に対するニーズが大きく、かつ継続的に存在する治療領域です。新たながん治療に対する緊急の必要性を考えると、がん領域の臨床試験は数が多く、新規治療薬、併用療法、有効性と副作用の両方について患者を注意深く観察する必要性などを含み、非常に複雑であることが多いです。臨床試験実施施設管理機関は、がん領域の臨床試験において貴重な存在であり、それぞれ独自の規制状況を持つさまざまな地域にまたがる多施設臨床試験を効率的に管理するために不可欠なインフラ、専門知識、調整を提供します。疼痛管理における臨床試験は、神経障害性疼痛、変形性関節症、片頭痛などの慢性疼痛状態に対する新しい鎮痛薬や介入の有効性と安全性を評価しようとするものです。痛みの主観的性質と、これらの試験でしばしば観察される高いプラセボ効果は、試験デザインと実施に洗練されたアプローチを要求します。

地域別の洞察

南北アメリカ、特に米国とカナダは、世界的に臨床試験の重要な舞台となっています。高度なヘルスケアインフラ、高い研究開発費、強固な規制環境がこの地域を臨床試験の好適な目的地とし、臨床試験実施施設管理機関の必要性を高めています。米国は臨床研究の中心地であり、製薬企業や研究機関が多数存在することが特徴です。21世紀治療法(21st Century Cures Act)などのイニシアチブにより、医薬品承認のための規制プロセスがさらに合理化され、より多くの臨床試験が奨励されています。欧州は、厳格な規制要件とともに、安全性と有効性に関する高い基準を特徴としています。欧州医薬品庁(EMA)は、加盟国間の規制の調和に重要な役割を果たしており、欧州全域での多施設臨床試験を促進しています。欧州は希少疾患と個別化医療における研究の最前線にあります。最近の取り組みでは、患者エンゲージメントを強化し、臨床試験にデジタル技術を取り入れることに重点を置いています。中東は、ヘルスケアインフラと研究活動を強化する政府のイニシアティブにより、臨床試験の状況においてますます重要性を増しています。イスラエル、サウジアラビア、アラブ首長国連邦などの国々は、バイオテクノロジーや製薬研究に投資しています。APAC地域では、大規模で多様な患者集団への対応、コスト効率の達成、規制枠組みの迅速な改善などの必要性から、臨床試験活動や治験施設管理機関のニーズが大きく伸びています。中国は、その膨大な人口と生物医学研究をますます支援する政府により、臨床試験の主要国となっています。中国の医薬品承認プロセスにおける最近の改革により、承認にかかる時間が大幅に短縮され、臨床研究の目的地として適しています。高度なヘルスケアシステムと高い医療費を誇る日本は、アジア太平洋における臨床試験の主要国です。インドは広大で遺伝的に多様な人口を抱え、コスト効率も高いことから、臨床試験の新たなリーダーとなっています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、臨床試験施設管理機関市場の評価において極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析は、臨床試験施設管理機関市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度:有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化:新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報:市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション:将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています:

1.臨床試験施設管理機関市場の市場規模および予測は?

2.臨床試験施設管理機関市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か?

3.臨床試験施設管理機関市場の技術動向と規制枠組みは?

4.臨床試験施設管理機関市場における主要ベンダーの市場シェアは?

5.臨床試験施設管理機関市場への参入に適した形態や戦略的手段は?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 健康問題のリスク増加と臨床試験の増加
      • 世界中で医薬品調査への民間および公的投資が増加
      • 強力な臨床試験規制枠組みと費用対効果の高い管理サービスの必要性
    • 抑制要因
      • 複数拠点間のコミュニケーションと調整に伴う複雑さ
    • 機会
      • 臨床試験施設管理業務における先進技術の統合
      • ヘルスケアインフラの改善に伴う臨床試験調査施設の拡張
    • 課題
      • 熟練した訓練を受けた人材の不足
  • 市場セグメンテーション分析
    • フェーズ:フェーズIII試験における厳格なデータ収集と参加者管理の必要性
    • 治療領域:腫瘍学研究の固有の複雑さと、迅速な開発サイクルと広範囲にわたる複数施設の調整の必要性
  • 市場ディスラプション分析
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 価格分析
  • 技術分析
  • 特許分析
  • 貿易分析
  • 規制枠組みの分析

第6章 臨床試験施設管理機関市場フェーズ別

  • フェーズI
  • フェーズII
  • フェーズIII
  • フェーズIV

第7章 臨床試験施設管理機関市場:サービス別

  • オンサイトモニタリング
  • プロジェクト管理
  • 規制コンプライアンス
  • サイト管理

第8章 臨床試験施設管理機関市場治療領域別

  • 心臓病学
  • 中枢神経系
  • 内分泌
  • 腫瘍学
  • 疼痛管理

第9章 南北アメリカの臨床試験施設管理機関市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の臨床試験施設管理機関市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの臨床試験施設管理機関市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス、2023
  • 競合シナリオ分析
    • Ichor Life Sciences、Ichor臨床試験サービスの開始により事業領域を拡大
    • LEO PharmaとICON plcの戦略的提携により、革新的な皮膚科臨床試験が強化される
    • ニュートラ、民間臨床調査の買収に関する基本合意書を締結
  • 戦略分析と提言

第13章 競合ポートフォリオ

  • 主要企業プロファイル
  • 主要製品ポートフォリオ
図表

LIST OF FIGURES

  • FIGURE 1. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET RESEARCH PROCESS
  • FIGURE 2. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET DYNAMICS
  • FIGURE 7. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE I, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE I, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE II, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE II, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE III, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE III, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE IV, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE IV, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY ONSITE MONITORING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY ONSITE MONITORING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PROJECT MANAGEMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PROJECT MANAGEMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY REGULATORY COMPLIANCE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY REGULATORY COMPLIANCE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SITE MANAGEMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SITE MANAGEMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY ENDOCRINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY ENDOCRINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 51. ARGENTINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 52. ARGENTINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 53. BRAZIL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 54. BRAZIL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 57. BRAZIL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 58. BRAZIL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 59. CANADA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 60. CANADA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 61. CANADA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 62. CANADA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 63. CANADA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 64. CANADA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 65. MEXICO CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 66. MEXICO CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 67. MEXICO CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 68. MEXICO CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 69. MEXICO CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 70. MEXICO CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 71. UNITED STATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 72. UNITED STATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 73. UNITED STATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 74. UNITED STATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 75. UNITED STATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 76. UNITED STATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 77. UNITED STATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 78. UNITED STATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 88. AUSTRALIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 90. AUSTRALIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 92. AUSTRALIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 93. CHINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 94. CHINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 95. CHINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 96. CHINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 97. CHINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 98. CHINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 99. INDIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 100. INDIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 101. INDIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 102. INDIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 103. INDIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 104. INDIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 105. INDONESIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 106. INDONESIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 107. INDONESIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 108. INDONESIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 109. INDONESIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 110. INDONESIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 111. JAPAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 112. JAPAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 113. JAPAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 114. JAPAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 115. JAPAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 116. JAPAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 117. MALAYSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 118. MALAYSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 119. MALAYSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 120. MALAYSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 121. MALAYSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 122. MALAYSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 124. PHILIPPINES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 126. PHILIPPINES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 128. PHILIPPINES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 129. SINGAPORE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 130. SINGAPORE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 131. SINGAPORE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 132. SINGAPORE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 133. SINGAPORE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 134. SINGAPORE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 136. SOUTH KOREA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 138. SOUTH KOREA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 139. SOUTH KOREA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 140. SOUTH KOREA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 141. TAIWAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 142. TAIWAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 143. TAIWAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 144. TAIWAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 145. TAIWAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 146. TAIWAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 147. THAILAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 148. THAILAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 149. THAILAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 150. THAILAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 151. THAILAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 152. THAILAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 153. VIETNAM CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 154. VIETNAM CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 155. VIETNAM CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 156. VIETNAM CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 157. VIETNAM CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 158. VIETNAM CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 167. DENMARK CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 168. DENMARK CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 169. DENMARK CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 170. DENMARK CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 171. DENMARK CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 172. DENMARK CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 173. EGYPT CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 174. EGYPT CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 175. EGYPT CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 176. EGYPT CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 177. EGYPT CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 178. EGYPT CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 179. FINLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 180. FINLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 181. FINLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 182. FINLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 183. FINLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 184. FINLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 185. FRANCE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 186. FRANCE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 187. FRANCE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 188. FRANCE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 189. FRANCE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 190. FRANCE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 191. GERMANY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 192. GERMANY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 193. GERMANY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 194. GERMANY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 195. GERMANY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 196. GERMANY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 197. ISRAEL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 198. ISRAEL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 199. ISRAEL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 200. ISRAEL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 201. ISRAEL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 202. ISRAEL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 203. ITALY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 204. ITALY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 205. ITALY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 206. ITALY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 207. ITALY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 208. ITALY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 210. NETHERLANDS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 211. NETHERLANDS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 212. NETHERLANDS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 213. NETHERLANDS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 214. NETHERLANDS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 215. NIGERIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 216. NIGERIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 217. NIGERIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 218. NIGERIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 219. NIGERIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 220. NIGERIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 221. NORWAY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 222. NORWAY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 223. NORWAY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 224. NORWAY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 225. NORWAY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 226. NORWAY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 227. POLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 228. POLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 229. POLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 230. POLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 231. POLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 232. POLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 233. QATAR CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 234. QATAR CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 235. QATAR CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 236. QATAR CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 237. QATAR CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 238. QATAR CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 239. RUSSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 240. RUSSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 241. RUSSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 242. RUSSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 243. RUSSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 244. RUSSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 246. SAUDI ARABIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 247. SAUDI ARABIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 248. SAUDI ARABIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 249. SAUDI ARABIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 250. SAUDI ARABIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 255. SOUTH AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 256. SOUTH AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 257. SPAIN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 258. SPAIN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 259. SPAIN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 260. SPAIN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 261. SPAIN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 262. SPAIN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 263. SWEDEN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 264. SWEDEN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 265. SWEDEN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 266. SWEDEN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 267. SWEDEN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 268. SWEDEN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 270. SWITZERLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 271. SWITZERLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 272. SWITZERLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 273. SWITZERLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2023 (USD MILLION)
  • TABLE 274. SWITZERLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2024-2030 (USD MILLION)
  • TABLE 275. TURKEY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 276. TURKEY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 277. TURKEY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES
目次
Product Code: MRR-8C74ADFBFDA3

[197 Pages Report] The Clinical Trials Site Management Organizations Market size was estimated at USD 7.38 billion in 2023 and expected to reach USD 8.00 billion in 2024, at a CAGR 8.65% to reach USD 13.21 billion by 2030.

Clinical trial site management organizations are responsible for recruiting patients, coordinating training and meetings for staff, managing study budgets, and more during various phases of clinical trials. They also help ensure that sites are compliant with relevant regulations, as well as make sure that all participants in the trial are receiving quality care. The utilization of site management organizations has surged considerably in recent years, with the prevalence of communicable and non-communicable diseases encouraging drug development activities. Moreover, investments made by government agencies and pharmaceutical and biopharmaceutical manufacturers and the need for cost-effective management of clinical trial activities also encourage the use of site management organizations. On the other hand, issues pertaining to managing and coordinating different clinical trial research sites and shortages of trained staff hinder their utilization. However, the adoption of innovative technologies in clinical trial management and monitoring, coupled with a continuous increase in the number of research sites across the globe, is expected to support the adoption of clinical trial site management services in the coming years.

KEY MARKET STATISTICS
Base Year [2023] USD 7.38 billion
Estimated Year [2024] USD 8.00 billion
Forecast Year [2030] USD 13.21 billion
CAGR (%) 8.65%

Phase: Need for ensuring the rigorous data collection and participant management in Phase III trials

During the Phase I clinical trial process, clinical trial site management organizations aid in developing detailed protocols, ensuring strict adherence to the overall trial plan, closely monitoring progress against objectives, providing clear communication between all parties involved, and coordinating with regulatory agencies. Additionally, these organizations may monitor recruitment efforts to ensure that appropriate patient populations are enrolled for accurate data collection. In Phase II clinical trials, clinical trial site management organizations focus on increasing staff size where necessary to handle increased workloads associated with larger sample sizes, providing sufficient resources to support increased participant visits and follow-up examinations, collecting high-quality data from participants accurately and efficiently, and assisting in ensuring that all assignments are completed in an organized and timely manner. During Phase III clinical trials, clinical trial site management organizations strive to maintain rigorous standards for data accuracy and consistency while protecting patient safety at all times. Strategies such as rigorous quality control measures throughout the entire process can help ensure data integrity and compliance with regulatory standards. In Phase IV clinical trials, the primary goal of clinical trial site management organizations is to evaluate and determine the long-term safety and effectiveness of the drug or device being tested through continued post-marketing surveillance activities such as additional patient follow-up visits or additional laboratory testing.

Therapeutic Areas: Inherent complexities of oncology studies and the need for rapid development cycles and extensive multi-site coordination

The field of cardiology focuses on diagnosing, understanding, and treating disorders related to the heart and blood vessels. Clinical trials in cardiology might encompass a broad spectrum of studies, from those investigating preventive measures and novel therapeutics for managing hypertension, coronary artery disease, heart failure, and arrhythmias to evaluating cutting-edge medical devices such as stents and pacemakers. The central nervous system realm, encompassing a range of neurological and psychiatric conditions, including Alzheimer's disease, Parkinson's disease, epilepsy, depression, and schizophrenia, is marked by a high degree of trial complexity. This is due to the intricacies of measuring outcomes that are often subjective or require special instruments. Clinical trial site management organizations play a critical role in CNS trials, facilitating the navigation through stringent regulatory environments and the implementation of specialized methodologies for patient assessment and outcome measurement. Endocrine trials focus on disorders of the endocrine system, including diabetes, thyroid disorders, and osteoporosis. Although many endocrine trials, particularly those related to diabetes, are large-scale studies requiring extensive patient enrollment and long-term follow-up, the operational demands vary widely across the spectrum of endocrine disorders. Clinical trial site management organizations are instrumental in these studies, offering expertise in patient recruitment, especially in reaching specific subpopulations and managing the logistical aspects of long-term follow-ups. Oncology is a therapeutic area with a significant and ongoing need for clinical trial site management organizations. Given the urgent need for new cancer treatments, oncology trials are numerous and often highly complex, involving novel therapeutic agents, combination therapies, and the need to closely monitor patients for both efficacy and adverse effects. Clinical trial site management organizations are valuable in oncology clinical trials, providing the essential infrastructure, expertise, and coordination to efficiently manage multicenter trials across different regions, each with its unique regulatory landscape. Clinical trials in pain management seek to evaluate the efficacy and safety of new analgesics or interventions for chronic pain conditions such as neuropathic pain, osteoarthritis, and migraines. The subjective nature of pain and the high placebo effect often observed in these trials demand a sophisticated approach to trial design and execution.

Regional Insights

The Americas, particularly the United States and Canada, represent a significant landscape for clinical trials globally. The region's advanced healthcare infrastructure, high research and development expenditure, and robust regulatory environment make it a preferred destination for clinical trials, thereby contributing to the need for clinical trial site management organizations. The U.S. is the epicenter of clinical research, characterized by the presence of a vast majority of pharmaceutical companies and research institutions. Initiatives such as the 21st Century Cures Act have further streamlined the regulatory process for drug approval, encouraging more clinical trials. Europe is characterized by its high standards for safety and efficacy alongside stringent regulatory requirements. The European Medicines Agency (EMA) plays a vital role in harmonizing regulations across member states, facilitating multicenter trials across the continent. Europe is at the forefront of research in rare diseases and personalized medicine. Recent initiatives focus on enhancing patient engagement and incorporating digital technologies in trials. The Middle East is increasingly becoming significant in the clinical trials landscape, driven by government initiatives to boost healthcare infrastructure and research activities. Countries such as Israel, Saudi Arabia, and the UAE are investing in biotechnology and pharmaceutical research. The APAC region has seen significant growth in the need for clinical trial activities and clinical trial site management organizations, primarily driven by the need to cater to the large and diverse patient population, achieve cost efficiencies, and rapidly improve regulatory frameworks. China has become a major nation for clinical trials due to its massive population and a government that is increasingly supportive of biomedical research. Recent reforms in China's drug approval processes have significantly reduced approval times, making it a suitable destination for clinical research. Japan, with its advanced healthcare system and high healthcare expenditure, is a leading country for clinical trials in the Asia Pacific. India is an emerging leader in clinical trials due to its vast, genetically diverse population and cost efficiencies.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Clinical Trials Site Management Organizations Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clinical Trials Site Management Organizations Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trials Site Management Organizations Market, highlighting leading vendors and their innovative profiles. These include Accel Clinical Services, Accelagen, Access Clinical Research, Altasciences, Celerion, ClinChoice, Clinical Development Solutions, CMIC HOLDINGS Co., LTD., Criterium, Inc., FIDELIS RESEARCH AD by BioIVT, FOMAT Medical Research Inc., George Clinical Pty Ltd,, Grand Pacific CRO, ICON PLC, IQVIA Inc., KV Clinical Research Services, L.E.K. Consulting LLC, MCRA, LLC, Medigence Solutions Pvt Ltd., Novotech, Parexel International Corporation, PPD Inc. by Thermo Fisher Scientific Inc., PROMETRIKA, LLC., ProTrials Research, Inc., Red Maple Trials Inc., SGS S.A., Veristat, LLC., Vial Health Technology, Inc., WIRB-Copernicus Group, Xylem Research LLP, and Zave Clinical Research Management.

Market Segmentation & Coverage

This research report categorizes the Clinical Trials Site Management Organizations Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Phase
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • Services
    • Onsite Monitoring
    • Project Management
    • Regulatory Compliance
    • Site Management
  • Therapeutic Areas
    • Cardiology
    • Central Nervous System
    • Endocrine
    • Oncology
    • Pain Management
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Clinical Trials Site Management Organizations Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clinical Trials Site Management Organizations Market?

3. What are the technology trends and regulatory frameworks in the Clinical Trials Site Management Organizations Market?

4. What is the market share of the leading vendors in the Clinical Trials Site Management Organizations Market?

5. Which modes and strategic moves are suitable for entering the Clinical Trials Site Management Organizations Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing risk of health issues and growing number of clinical trials
      • 5.1.1.2. Rising private and public investments in pharmaceutical research across the globe
      • 5.1.1.3. Strong clinical trial regulatory frameworks and need for cost-effective management services
    • 5.1.2. Restraints
      • 5.1.2.1. Complexities associated with multi-site communication and coordination
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of advanced technologies in clinical trial site management operations
      • 5.1.3.2. Expansion of clinical trial research facilities with improving healthcare infrastructure
    • 5.1.4. Challenges
      • 5.1.4.1. Limited availability of skilled and trained personnel
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Phase: Need for ensuring the rigorous data collection and participant management in Phase III trials
    • 5.2.2. Therapeutic Areas: Inherent complexities of oncology studies and the need for rapid development cycles and extensive multi-site coordination
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Clinical Trials Site Management Organizations Market, by Phase

  • 6.1. Introduction
  • 6.2. Phase I
  • 6.3. Phase II
  • 6.4. Phase III
  • 6.5. Phase IV

7. Clinical Trials Site Management Organizations Market, by Services

  • 7.1. Introduction
  • 7.2. Onsite Monitoring
  • 7.3. Project Management
  • 7.4. Regulatory Compliance
  • 7.5. Site Management

8. Clinical Trials Site Management Organizations Market, by Therapeutic Areas

  • 8.1. Introduction
  • 8.2. Cardiology
  • 8.3. Central Nervous System
  • 8.4. Endocrine
  • 8.5. Oncology
  • 8.6. Pain Management

9. Americas Clinical Trials Site Management Organizations Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Clinical Trials Site Management Organizations Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Clinical Trials Site Management Organizations Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Ichor Life Sciences Expands Its Horizon Through the Launch of Ichor Clinical Trial Services
    • 12.3.2. Strategic Alliance between LEO Pharma and ICON plc Bolsters Innovative Dermatology Clinical Trials
    • 12.3.3. Neutra Executes LOI to Acquire Private Clinical Research
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio